Investing in Information Technology and Healthcare

News


ATHENIAN NEWS
Innovation awards honor inventors, entrepreneurs
(March 20, 2013) Athenian's Dave Scholl honored by The Innovation Awards for his notable advances in business and technology. Read more...

VC sees opportunity in sequester
upstart business logo
(February 28, 2013) On the spot as the looming federal sequestration unfolds, Upstart’s venerable Kent Berhard seeks expert opinion from Athenian’s Karl Elderkin. Read more...

Athenian's Dave Scholl keynotes two prominent life science events
NationwideBio WV
(February 25, 2013) Athenian's Dave Scholl is featured key note presenter at Nationwide Children's Hospital's Technology Showcase and West Virginia Bio Science Summit. Read more...

Athenian further defining niche strategy in off-the-beaten-path investments: FLORIDATampaBayBusJournal
(February 15, 2013) Athenian Venture Partners is actively shopping the state for more companies in which it can put its money to work. Read more...

Mary Strother featured in The Glasshammer
TheGlasshammer
(January 28, 2013) Voice of Experience: Mary Strother Managing Director, Investor Relations, Athenian Venture Partners. Read more...

Mary Strother on judging panel for Startup Weekend Athens

CBF
(January 25, 2013) Ohio University to host second Startup Weekend Athens for tech entrepreneurs. Read more...

Athenian's Mitch Rosich discusses what it takes in the leadership of IT start-ups to get them off the ground VentureBeatLogo
(December 12, 2012) Straight from a VC's mouth: 5 things I look for in a CEO Read more...

Mary Strother featured in The NextWomen
(December 11, 2012) Mary Strother: What is Investor Relations & How Can Women Get into the field? Read more...

Athenian in Huffington Post
(December 3, 2012)How the Midwest is becoming an Entrepreneurial Hotspot Read more...

Mary Strother with Athenian has article published in Women 2.0
(November 26, 2012) One woman's journey to investor relations Read more...

Athenian recognized as rare breed: having a bubble-era fund with significant remaining value
vcj logo
(October 1, 2012) Venture Capital Journal quotes Karl Elderkin in bubble-era funds cover story. With the majority of bubble-era funds reporting negative IRRs, Athenian's investment strategy is paying off in much better returns. read more here on page 36 thru 47...

The Term Sheet tops its daily publication with buzz on Athenian
fortune dan primack
(September 26, 2012) Fortune Term Sheet - Ohio produces top VC fund: While Silicon Valley insider Mark Kvamme could help save Ohio's economy, it seems like the investment community in the Buckeye state has been doing pretty well... VC firm Athenian Venture Partners...find out more here...

We see deals that other VCs fly right over...
Med City News
(September 25, 2012) Midwest IT/Lifescience VC Read more...

Athenian shows that Ohio is a leader in investment opportunities.
hi Velocity
(September 6, 2012) Karl Elderkin explains that Athenian's location in the Midwest puts them in a prime location for finding profitable investments in key innovation states like Ohio.
find out more here...

Techli
Techli logo
(August 16, 2012) Investing in Ohio Startups Pays off Big, According to VC. Read more...

Athenian Boasts a Top Venture IRR for the 2003 Vintage
PEhub logo
(August 7, 2012) Small venture funds "can boast eye-popping returns that larger funds can only lust after."
find out more here...


Athenian input sought on IPOs as exit strategy
(August 3, 2012) IPOs not much of an exit plan for investors or option for raising cash.
find out more here...

Athenian Venture Partners fund ranked number one by Preqin

marketwatch
(August 1, 2012) Based on its 1,669 venture capital funds on file, including 38 funds of the 2003 vintage, Preqin determined that Athenian is currently the hightest ranking of the 2003 U.S. venture capital funds in both net return multiple (4.95x) and IRR (31%). find out more here...
 
Athenian on 4 reasons why VCs should check out Ohio
VentureBeatLogo

(July 15, 2012) Mitch Rosich backs up why investing between coasts makes a lot of sense: 1. untapped investment opportunities, 2. attractive deals for the right price, 3. long-term vision and 4. supporting its entrepreneurs. find out more here...


Athenian on Crowdfunding in peHUB
PEhub logo
(July 9, 2012) Karl Elderkin explains pros and cons of crowdfunding and VC. find out more here...
 
5th Annual BioVenture & Innovation Showcase
(May 24, 2012) Innovation showcase highlights Athens area’s leadership
find out more here...

$44M partial acquisition by Norwest Venture Partners

(April 3, 2012) Athenian has worked closely with Manta's management to grow the company since its initial investment in 2000, and its performance has exceeded all expectations. Manta's focused vision and brilliant execution shows the world that exciting technology companies are not geographically limited to the east and west coasts, but can also be built in Ohio and the surrounding region. Bringing on NVP is yet another proof point of the company's sector dominance in the online SMB community. Read more...
 
Athenian on Regional M&A Activity - Karl Elderkin
Region buzzing with M&A deals amid recovery (January 13, 2012). Read full Columbus Business First article here.


PORTFOLIO UPDATE


Cyber Rain
Cyber Rain
(May 18, 2013)

Cyber Rain's full line of weather-based controllers is the first outdoor technology to earn the EPA's WaterSense label and was recently named a top ten environmentally innovative product for 2013 by the editors of Building Green’s GreenSpec and Environmental Building News. Read more...

(April 9, 2012) Makers of web-based, central irrigation systems announced a partnership with Weather Underground, providers of weather information. Read more...
 
Baxano
baxanoclip_image002_007.jpg
(February 19, 2013) Baxano announces surpassing significant milestone: Over 5,000 patients, representing nearly 10,000 neural foramen, have now been treated with the iO-Flex® System for lumbar spinal decompression since the time the product became commercially available in late 2009. Read more...

(October 9, 2012) Baxano, Inc., Expands Minimally Invasive Technology Platform for Use in Spinal Fusion Applications
Read more...

(March 6, 2012) Baxano, Inc., a Silicon Valley-based medical device company and manufacturer of the iO-Flex(R) System for spinal decompression surgery has received CE Mark approval allowing for future expansion into European markets. Read more...

Takeda to Acquire LigoCyte Pharmaceuticals, Inc
LigoCyte Logo Taketa Logo
(Osaka, Japan, Oct. 5, 2012, Deerfield, Ill. and Bozeman, Mont., Oct. 4, 2012) – Takeda Pharmaceutical Company Limited (Takeda) and LigoCyte Pharmaceuticals, Inc. jointly announced today that Takeda’s wholly-owned subsidiary, Takeda America Holdings, Inc. and LigoCyte Pharmaceuticals, Inc. have entered into a definitive agreement for Takeda to acquire LigoCyte for an upfront payment of $60 million, with future contingent consideration based on the progress of development projects. LigoCyte is a privately-held biopharmaceutical company specializing in innovative vaccine products headquartered in Bozeman, Montana. Its lead product, a vaccine to prevent norovirus gastroenteritis, is in phase I/II of clinical development. Read More...

Manta Media


Manta Logo
(October 3, 2012) Manta Media rose from 99 last year and has been ranked 57 on the latest Business Insider Digital 100 for 2012 (The site’s annual ranking of the most valuable private tech companies, based on revenue.) Read more...

(September 17, 2012) Pam Springer featured in pandodaily discussing how Manta is cornering the "elusive small business market". Read more...

(July 18, 2012) Pam Springer, CEO of Manta, was interviewed by FOX Business News anchor Lauren Simonetti, live at FOX’s New York City studios regarding the results of Manta’s Q2 Wellness Index survey. Since launching in 2011, the Manta SMB Wellness Indexes have consistently garnered between 45-65 million media impressions each. They are frequently covered by FOX News, Yahoo, The Huffington Post, Business Insider, and the New York Times. Read more...

(March 13, 2012) Manta launches powerful connection & recommendation feature to help small businesses grow their referral network, while survey finds that a majority of small business owners experience more growth from referrals than Facebook & LinkedIn. Read more...

Aerpio Therapeutics
Akebia Therapeutics
(September 19, 2012) Aerpio Therapeutics Initiates Phase 1b/2a Trial of AKB-9778 in Diabetic Macular Edema. Read more..

(January 9, 2012)
New Company, Aerpio Therapeutics, is spun out of Cincinnati, OH-based Akebia Therapeutics, to Advance Novel Tie-2 Activators and HIF-1a Stabilizers for Multiple Diseases Read more..

Comet Solutions
Comet Logo
(September 17, 2012) Comet's 200% 2011 growth yields continued Asia expansion: Shanghai Read more...

(August 31, 2012) Comet Solutions(R) Expands Customer-Facing Team to Capitalize on GrowthCompany Names Steve Brown VP of Global Sales, While Also Enhancing U.S. Sales and Support Teams Read more...

(June 27, 2012)
Comet Solutions: 2012 expansion into Japan follows 220% revenue growth in China for 2011. Read more...
 
(March 1, 2012) Comet Solutions raises $4M in capital. Comet Solutions Inc., a maker of software concept engineering, has raised $4 million in Series C financing. Athenian Venture Partners led the round, with participation from Sun Mountain Capital, current investor Tri-State Growth Capital Fund. The company's last round of Series B financing closed in December 2009. Read full press release here...

Comet Solutions Increases Sales by 150% Over Previous Year, with half of its business coming from Asia. New customer orders accounted for 70% of the company’s global revenue, with revenue in China alone exceeding 220% growth. In addition, Comet announced new customer wins and the opening of an office in Southfield, Michigan. Read full press release here...

Prioria Robotics
Prioria new
(June 25, 2012)
Prioria Robotics Spies $5.5M for Unmanned Aircraft. Read more...
Akebia
Akebia Logo
(April 20, 2012) 2012 Innovation Awards: Emerging Innovation winner Akebia. Read more...

Micromet

Micromet, Inc. (MITI)

Micromet was acquired by Amgen
for $11 per share in cash, a 33% increase over the prior day's closing price. The transaction, which values Micromet at approximately $1.16 billion, was unamimously approved by both the Amgen and Micromet Board of Directors.